I
Isaac Yang
Researcher at University of California, Los Angeles
Publications - 301
Citations - 6895
Isaac Yang is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Medicine & Radiosurgery. The author has an hindex of 41, co-authored 266 publications receiving 5676 citations. Previous affiliations of Isaac Yang include University of Utah & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
The role of microglia in central nervous system immunity and glioma immunology
TL;DR: Their versatility in bridging the gap between the immune-privileged CNS and the peripheral immune system, in addition to their significant numbers in gliomas, makes them an attractive candidate in immunotherapy forgliomas.
Journal ArticleDOI
Utilizing virtual and augmented reality for educational and clinical enhancements in neurosurgery
Panayiotis E. Pelargos,Daniel T. Nagasawa,Carlito Lagman,Stephen Tenn,Joanna V. Demos,Seung J. Lee,Timothy T. Bui,Natalie E. Barnette,Nikhilesh S. Bhatt,Nolan Ung,Ausaf A. Bari,Neil A. Martin,Isaac Yang +12 more
TL;DR: A historical perspective of the development of VR and AR technologies is presented, its current uses are analyzed, and its emerging applications in the field of neurosurgery are discussed.
Journal ArticleDOI
The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments
Winward Choy,Won Kim,Daniel T. Nagasawa,Stephanie Stramotas,Andrew Yew,Quinton Gopen,Andrew T. Parsa,Isaac Yang +7 more
TL;DR: Treatment for meningiomas that are recurrent, aggressive, or refractory to conventional treatments will include combinations of targeted molecular agents as a result of continued progress in the understanding of genetic and biological changes associated withMeningioma.
Journal ArticleDOI
The natural history of untreated sporadic vestibular schwannomas: a comprehensive review of hearing outcomes.
Michael E. Sughrue,Isaac Yang,Derick Aranda,Khadja Lobo,Lawrence H. Pitts,Steven W. Cheung,Andrew T. Parsa +6 more
TL;DR: These data suggest that a growth rate of > 2.5 mm/year is a better predictor of hearing loss than the initial tumor size for patients undergoing observation management of VSs < 25 mm in largest diameter.
Journal ArticleDOI
Craniopharyngioma: a comparison of tumor control with various treatment strategies
Isaac Yang,Michael E. Sughrue,Martin J. Rutkowski,Rajwant Kaur,Michael E. Ivan,Derick Aranda,Igor J. Barani,Andrew T. Parsa +7 more
TL;DR: Estimates of outcome for a variety of treatment combinations are provided, as not all treatments are an option for all patients with these tumors.